ClinicalTrials.gg

Program

yeast .beta.-d-glucan

Also written as “TR987 0.1% gel + Standard of Care”, “GLYC-101 gel (1.0 %)” and “GLYC-101 Gel (0.1%)”.

Its studies are mostly in Varicose Ulcer · Wounds and Injuries, led by TR Therapeutics.

Furthest: phase 3, since Nov 24, 20244 company-led studies, 2 open or runningNext primary completion: Dec 2026 (phase 3)

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
TR Therapeutics42 open or runningphase 3since Nov 24, 2024Apr 7, 2008Dec 2026phase 3 · NCT06707103

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Apr 7, 2008First study: phase 2 study in Wounds and InjuriesFirst studyNCT00656474 · 12 enrolled · United States
  2. Nov 14, 2008Phase 2 study in Wounds and InjuriesNCT00792688 · 26 enrolled · United States
  3. Nov 24, 20242 phase 3 studies in Varicose UlcerNCT06707103, NCT06707090

Ahead

  1. Dec 2026Primary completion: phase 3 study in Varicose UlcerNCT06707103
  2. Dec 2027Primary completion: phase 3 study in Varicose UlcerNCT06707090

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 4 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT06707103Varicose Ulcer · United States, Australia3RecruitingDec 2026312
NCT06707090Varicose Ulcer · United States3RecruitingDec 2027312
NCT00792688Wounds and Injuries · United States2CompletedJan 201026
NCT00656474Wounds and Injuries · United States2CompletedApr 200812

How it is read

Names in the registry

  • “TR987 0.1% gel + Standard of Care”, 2 entries
  • “GLYC-101 gel (1.0 %)”, 1 entry
  • “GLYC-101 Gel (0.1%)”, 1 entry
  • “GLYC-101 Gel (1.0%)”, 1 entry

Codes read as this program: TR987.

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.